Xiaoping Song

4PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer diagnosisGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 30, 2023
Selumetinib overcomes gefitinib primary and acquired resistance by regulating MIG6/STAT3 in NSCLC.

Xiaoping Song, Lina Wang, Wei Tang

|Apr 08, 2021
FGFR leads to sustained activation of STAT3 to mediate resistance to EGFR-TKIs treatment.

Xiaoping Song, Wei Tang, Hui Peng

Pageof 1